Pegylated liposomal doxorubicin and gemcitabine in a fixed dose rate infusion for the treatment of patients with poor prognosis of recurrent ovarian cancer: A phase Ib study

1. Crespo, G.
2. Sierra, M.
3. Losa, R.
4. Berros, J.P.
5. Villanueva, N.
6. Fra, J.
7. Fonseca, P.J.
8. Luque, M.
9. Fernández, Y.
10. Blay, P.
11. Sanmamed, M.
12. Muriel, C.
13. Esteban, E.
14. Lacave, A.J.